{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:00:20Z","timestamp":1789761620617,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 126040"],"award-info":[{"award-number":["MOP 126040"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PPP136719"],"award-info":[{"award-number":["PPP136719"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada Foundation for Innovation, and Ontario Research Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.bmc.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T16:46:19Z","timestamp":1488818779000},"page":"2643-2656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis"],"prefix":"10.1016","volume":"25","author":[{"given":"Amit","family":"Sarswat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wasilewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai K.","family":"Chakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica M.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Caprariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chithra M.","family":"Muthuramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Stys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi P.","family":"Kotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.03.006_b0005","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"Gy\u00f6rgy","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmc.2017.03.006_b0010","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbagrm.2013.07.003","article-title":"Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis","volume":"1829","author":"Wang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmc.2017.03.006_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/0929867323666151118120710","article-title":"Peptidyl arginine deiminases and neurodegenerative diseases","volume":"23","author":"Tu","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2017.03.006_b0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nsmb799","article-title":"Structural basis for Ca2+-induced activation of human PAD4","volume":"11","author":"Arita","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmc.2017.03.006_b0025","doi-asserted-by":"crossref","first-page":"e51660","DOI":"10.1371\/journal.pone.0051660","article-title":"Functional roles of the non-catalytic calcium-binding sites in the N-terminal domain of human peptidyl arginine deiminase 4","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2017.03.006_b0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/cb500933j","article-title":"Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design","volume":"10","author":"Slade","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2017.03.006_b0035","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Vossenaar","year":"2003","journal-title":"BioEssays"},{"key":"10.1016\/j.bmc.2017.03.006_b0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-4165(88)90088-8","article-title":"Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues","volume":"966","author":"Watanabe","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmc.2017.03.006_b0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jcp.1041450219","article-title":"Estrogen regulates peptidylarginine deiminase levels in a rat pituitary cell line in culture","volume":"145","author":"Nagata","year":"1990","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bmc.2017.03.006_b0050","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jnr.22255","article-title":"Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain","volume":"88","author":"Shimada","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2017.03.006_b0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biochi.2012.09.029","article-title":"Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice","volume":"95","author":"van Beers","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2017.03.006_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbpb.2013.10.003","article-title":"Three isozymes of peptidylarginine deiminase in the chicken: molecular cloning, characterization, and tissue distribution","volume":"167","author":"Shimizu","year":"2014","journal-title":"Comp Biochem Physiol B: Biochem Mol Biol"},{"key":"10.1016\/j.bmc.2017.03.006_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/ard.2011.151712","article-title":"Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis","volume":"71","author":"Darrah","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bmc.2017.03.006_b0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.0022-202X.2004.23568.x","article-title":"Peptidylarginine deiminase isoforms 1\u20133 are expressed in the epidermis and involved in the deimination of K1 and filaggrin","volume":"124","author":"Nachat","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bmc.2017.03.006_b0075","doi-asserted-by":"crossref","first-page":"49562","DOI":"10.1074\/jbc.M208795200","article-title":"Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes","volume":"277","author":"Nakashima","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2017.03.006_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2014.05.007","article-title":"Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis","volume":"273","author":"Bradford","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.bmc.2017.03.006_b0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cne.20102","article-title":"Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis","volume":"473","author":"Nicholas","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bmc.2017.03.006_b0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI117300","article-title":"Myelin in multiple sclerosis is developmentally immature","volume":"94","author":"Moscarello","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2017.03.006_b0095","doi-asserted-by":"crossref","first-page":"11387","DOI":"10.1523\/JNEUROSCI.3349-06.2006","article-title":"Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation","volume":"26","author":"Mastronardi","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2017.03.006_b0100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/labinvest.3700748","article-title":"Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities","volume":"88","author":"Wood","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.bmc.2017.03.006_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1242\/dmm.000729","article-title":"Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system","volume":"1","author":"Musse","year":"2008","journal-title":"Dis Models Mech"},{"key":"10.1016\/j.bmc.2017.03.006_b0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11064-006-9144-5","article-title":"The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis","volume":"32","author":"Moscarello","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bmc.2017.03.006_b0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/ml300377d","article-title":"Interrogation of the active site of protein arginine deiminase (PAD) using designer probes","volume":"4","author":"Bello","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.03.006_b0120","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1021\/ja0576233","article-title":"A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation","volume":"128","author":"Luo","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2017.03.006_b0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2017.03.006_b0130","first-page":"467","article-title":"Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis","volume":"6","author":"Moscarello","year":"2013","journal-title":"Dis Models Mech"},{"key":"10.1016\/j.bmc.2017.03.006_b0135","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1021\/jm301755q","article-title":"Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal model","volume":"56","author":"Wei","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.03.006_b0140","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/bi061180d","article-title":"Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization","volume":"45","author":"Luo","year":"2006","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.bmc.2017.03.006_b0145","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1021\/jm2008985","volume":"54","author":"Causey","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.03.006_b0150","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/ml300288d","article-title":"d-Amino acid based protein arginine deiminase inhibitors: synthesis, pharmacokinetics, and in cellulo efficacy","volume":"3","author":"Bicker","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.03.006_b0155","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1021\/jm501636x","article-title":"Design, synthesis, and biological evaluation of tetrazole analogs of Cl-Amidine as protein arginine deiminase inhibitors","volume":"58","author":"Subramanian","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.03.006_b0160","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bmcl.2012.11.102","article-title":"Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors","volume":"23","author":"Bozdag","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.03.006_b0165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1039\/c3md00091e","article-title":"Discovery of a structurally novel, drug-like and potent inhibitor of peptidylarginine deiminase","volume":"4","author":"Ferretti","year":"2013","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2017.03.006_b0170","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1073\/pnas.1110789109","article-title":"A\u03b2 neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-d-aspartate receptors","volume":"109","author":"You","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2017.03.006_b0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08916939509008017","article-title":"Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL\/J mice","volume":"21","author":"Tuohy","year":"1995","journal-title":"Autoimmunity"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089616312937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089616312937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:48:35Z","timestamp":1760834915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089616312937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0968089616312937"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.03.006","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}